Trials / Unknown
UnknownNCT01213667
Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD
Pharmacogenetics in Anti-VEGF Treatment Non-responders Suffering Exudative Age-related Macular Degeneration (AMD): Genetic Correlations and Intraocular Cytokine Concentrations
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- University of Cologne · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
To assess genetic features and intraocular cytokine profiles of non-responders to anti-VEGF treatment of exudative age-related macular degeneration. Also to assess necessity and frequency of pro re nate medical re-treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ranibizumab | upload (three monthly injections), re-treatment as needed |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2010-10-04
- Last updated
- 2016-10-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01213667. Inclusion in this directory is not an endorsement.